Document Detail


Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
MedLine Citation:
PMID:  12909218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To characterize non-albicans Candida oral infections in patients with head-and-neck cancer receiving external beam radiotherapy (EBRT) with or without concurrent chemotherapy. METHODS AND MATERIALS: Thirty-seven patients with head-and-neck cancer received EBRT in 2.0-Gy daily fractions to a median dose of 60.4 Gy (range 38-82.8, mean 64.6). They were followed for oropharyngeal candidiasis (OPC) confirmed by positive examination, positive KOH smear, and/or positive swab or swish culture. Samples were identified and plated on chromogenic media to identify non-albicans yeasts. Colonies were plated on Sabouraud dextrose slants for microdilution antifungal susceptibility testing to fluconazole. DNA typing, including karyotyping, restriction fragment length polymorphism analysis, and Southern blot hybridization with the moderately repetitive Ca3 probe, was performed on selected isolates to confirm individual species. RESULTS: Of the 37 patients, 10 (27%) developed OPC, and 26 (70.3%) displayed Candida carriage state. The median EBRT dose at time of positive culture was 22.5 Gy and at time of OPC was 28.6 Gy. Of the 6 patients receiving chemotherapy and EBRT, 4 (66%) developed OPC at median dose of 27.6 Gy. Three (8%) of 37 patients were infected with non-albicans Candida, and 3 (30%) of all 10 infections were caused by these organisms. CONCLUSION: Non-albicans Candida is emerging as a relatively common cause of OPC in head-and-neck cancer patients. Chromogenic media are helpful to screen these infections. Our data also suggest a greater likelihood of developing OPC in patients receiving concomitant chemotherapy and EBRT.
Authors:
Marta C Dahiya; Spencer W Redding; Rajiv S Dahiya; Tony Y Eng; William R Kirkpatrick; Brent J Coco; Lee C Sadkowski; A W Fothergill; Annette Waite; Michael G Rinaldi; Thomas F Patterson; Charles R Thomas
Related Documents :
67688 - Polichemotherapy of advanced head and neck malignancies.
2045198 - Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
10360608 - Evaluation of tomudex in patients with recurrent or metastatic squamous cell carcinoma ...
517928 - Value of radionucleotide scanning in the staging of head and neck carcinoma.
11019998 - Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients prese...
8385058 - Intraoperative radiation therapy in gynecologic cancer: the mayo clinic experience.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  57     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-08-11     Completed Date:  2003-10-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  79-83     Citation Subset:  IM    
Affiliation:
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. martadahiya@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Candida / classification,  isolation & purification
Candida tropicalis / isolation & purification
Candidiasis, Oral / diagnosis*,  drug therapy,  microbiology*
Female
Fluconazole / therapeutic use
Head and Neck Neoplasms / radiotherapy*
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Radiotherapy / adverse effects*
Chemical
Reg. No./Substance:
86386-73-4/Fluconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma.
Next Document:  The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response,...